Table 1.
Summary of the three real-world datasets used to benchmark the performance of the callers
| Name | HPV HIVID | HBV HIVID | HBV WGS |
|---|---|---|---|
| Samples | 135 | 426 × 2 | 88 × 2 |
| Tissue | Cervical cancer | HCC (tumor/control) | HCC (tumor/control) |
| Sequencing method | HIVID | HIVID | WGS |
| Virus integrated | HPV | HBV | HBV |
| Sensitivity tested by | 75 Sanger-validated calls | 145 Sanger-validated calls | 246 HIVID calls |
| Precision tested by | RNA-seq | RNA-seq | 246 HIVID calls |